Merck Pipeline
Lead-in Language The chart below reflects the Company’s research pipeline as of August 1, 2018. Candidates shown in Phase 3 include specific products and the date such
Download Merck Pipeline
Information
Domain:
Source:
Link to this page:
Documents from same domain
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.merck.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KEYTRUDAsafely and effectively. See full prescribing
M-M-R II (MEASLES, MUMPS, and RUBELLA VIRUS …
www.merck.com1 M-M-R®II (MEASLES, MUMPS, and RUBELLA VIRUS VACCINE LIVE) DESCRIPTION M-M-R®II (Measles, Mumps, and Rubella Virus Vaccine Live) is a live virus vaccine for vaccination ...
Medication Guide JANUMET - Merck.com
www.merck.comMedication Guide JANUMET®XR (JAN-you-met XR) (sitagliptin and metformin hydrochloride extended-release) Tablets Read this Medication Guide carefully before you start taking JANUMETXR and each time you get a refill.
Medication Guide - Merck.com
www.merck.com1 Medication Guide JANUVIA® (jah-NEW-vee-ah) (sitagliptin) Tablets Read this Medication Guide carefully before you start taking JANUVIA and each time you get a …
Patient Information EMEND (EE mend) (aprepitant) …
www.merck.comPatient Information EMEND® (EE mend) (aprepitant) capsules EMEND® (EE mend) (aprepitant) for oral suspension Read this Patient Information before you start taking EMEND and each time you get a refill.
FDA-Approved Patient Labeling - Merck.com
www.merck.com1 FDA-Approved Patient Labeling NEXPLANON (etonogestrel implant) Radiopaque Subdermal Use Only NEXPLANON does not protect against HIV infection (the virus that causes AIDS) or other sexually transmitted diseases.
Proposed Prescribing Information (USPI) Singulair
www.merck.com2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Asthma SINGULAIR® is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12months of age and older.
For injection: 100 mg of lyophilized infliximab-abda …
www.merck.com1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RENFLEXIS safely and effectively. See full prescribing information …
HIGHLIGHTS OF PRESCRIBING INFORMATION - …
www.merck.com1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NEXPLANON safely and effectively. See full prescribing
GARDASIL9 - Merck & Co.
www.merck.com1 Patient Information about GARDASIL®9 (pronounced “gard-Ah-sill nīn”) (Human Papillomavirus 9-valent Vaccine,Recombinant) Read this information with care before getting GARDASIL®9.
Related documents
Pemetrexed Tumore del polmone Non Small Cell …
salute.regione.emilia-romagna.itGrefo - raccomandazioni evidence based Pemetrexed Tumore del polmone, Non Small Cell Lung Cancer (NSCLC), non squamoso, mantenimento dopo I° linea
Chemotherapy Sequencing Guide – For therapies …
sites.mckesson.comBevacizumab Bleomycin Carboplatin Cisplatin Cyclophosphamide Cytarabine Dacarbazine Docetaxel Doxorubicin Epirubicin Etoposide Fludarabine Fluorouracil Gemcitabine Ifosfamide Irinotecan Leucovorin Liposomal Oxaliplatin Methotrexate Mitomycin Paclitaxel Pemetrexed Pralatrexate Topotecan Vincristine Vinorelbine
United States Court of Appeals for the Federal Circuit
www.cafc.uscourts.govUnited States Court of Appeals for the Federal Circuit _____ ELI LILLY AND COMPANY, Plaintiff-Appellee v. TEVA PARENTERAL MEDICINES, INC., APP
Page 1 of 2 Regimen title: Pemetrexed and …
www.londoncanceralliance.nhs.ukPage 1 of 2 Reason for Update: Network update Version: 1.1 Approved by Consultant: J. Spicer Supersedes: All other versions Date: 21/01/2008
SCHEDA FARMACO - osservatorioinnovazione.net
www.osservatorioinnovazione.netESTAV Centro •Sede legale 50125 Firenze Viale Michelangiolo 41 • Telefono 055 6577 328-453 • Fax 055 6577547 P.I. e C.F. 05577300485 • www. estav-centro.toscana.it • direzione@estav-centro.toscana.it
Tysabri REMS: Pre-Infusion Patient Checklist
www.fda.govTitle: Tysabri REMS: Pre-Infusion Patient Checklist Author: fda/cder Subject: Tysabri REMS Created Date: 5/14/2013 2:24:26 PM